World Health Organization (WHO) has unveiled a comprehensive publication highlighting critical regulatory considerations for harnessing the potential of artificial intelligence (AI) in healthcare.
The document underscores the need to prioritize AI systems' safety and efficacy, rapid deployment for those in need, and fostering collaborative dialogue among various stakeholders, including developers, regulators, manufacturers, health professionals, and patients.
WHO acknowledges the capabilities of AI in areas such as bolstering clinical trials, enhancing medical diagnoses and treatments, promoting self-care and person-centered care, and augmenting healthcare professionals' knowledge and competencies.
North America, particularly the U.S., is a pivotal region in the AI in ...